Ultrapure Filter does not Confer Short-Term Benefits over Two Reverse Osmosis Systems in Chronic Hemodialysis Patients.


Journal

The Israel Medical Association journal : IMAJ
ISSN: 1565-1088
Titre abrégé: Isr Med Assoc J
Pays: Israel
ID NLM: 100930740

Informations de publication

Date de publication:
Jan 2019
Historique:
entrez: 28 1 2019
pubmed: 28 1 2019
medline: 28 5 2019
Statut: ppublish

Résumé

Dialysate purity contributes to the inflammatory response that afflicts hemodialysis patients. To compare the clinical and laboratory effects of using ultrapure water produced by a water treatment system including two reverse osmosis (RO) units in series, with a system that also includes an ultrapure filter (UPF). We performed a retrospective study in 193 hemodialysis patients during two periods: period A (no UPF, 6 months) and period B (same patients, with addition of UPF, 18 months), and a historical cohort of patients treated in the same dialysis unit 2 years earlier, which served as a control group. Mean C-reactive protein, serum albumin and systolic blood pressure worsened in period B compared to period A and in the controls. A double RO system to produce ultrapure water is not inferior to the use of ultrapure filters.

Sections du résumé

BACKGROUND BACKGROUND
Dialysate purity contributes to the inflammatory response that afflicts hemodialysis patients.
OBJECTIVES OBJECTIVE
To compare the clinical and laboratory effects of using ultrapure water produced by a water treatment system including two reverse osmosis (RO) units in series, with a system that also includes an ultrapure filter (UPF).
METHODS METHODS
We performed a retrospective study in 193 hemodialysis patients during two periods: period A (no UPF, 6 months) and period B (same patients, with addition of UPF, 18 months), and a historical cohort of patients treated in the same dialysis unit 2 years earlier, which served as a control group.
RESULTS RESULTS
Mean C-reactive protein, serum albumin and systolic blood pressure worsened in period B compared to period A and in the controls.
CONCLUSIONS CONCLUSIONS
A double RO system to produce ultrapure water is not inferior to the use of ultrapure filters.

Identifiants

pubmed: 30685897

Substances chimiques

Dialysis Solutions 0
Serum Albumin 0
C-Reactive Protein 9007-41-4

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5-9

Auteurs

Ayelet Grupper (A)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Moshe Shashar (M)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Talia Weinstein (T)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Orit Kliuk Ben Bassat (O)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Shoni Levy (S)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Idit F Schwartz (IF)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Avital Angel (A)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Aharon Baruch (A)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Avishay Grupper (A)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Gil Chernin (G)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Doron Schwartz (D)

Department of Nephrology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH